ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy
European Urology Open Science
◽
10.1016/j.euros.2021.09.015
◽
2021
◽
Vol 34
◽
pp. 70-78
Author(s):
Karen A. Autio
◽
Emmanuel S. Antonarakis
◽
Tina M. Mayer
◽
Daniel H. Shevrin
◽
Mark N. Stein
◽
...
Keyword(s):
Prostate Cancer
◽
Radical Prostatectomy
◽
Abiraterone Acetate
◽
Phase 2
◽
Recurrent Prostate Cancer
◽
Phase 2 Trial
◽
Randomized Phase 2
Download Full-text
Related Documents
Cited By
References
Phase 2, randomized, 3-arm study of abiraterone acetate and prednisone (AAP), AAP plus degarelix (AAP+D), and degarelix (D) alone for patients (pts) with biochemically-recurrent prostate cancer (PC) following radical prostatectomy (RP).
Journal of Clinical Oncology
◽
10.1200/jco.2018.36.15_suppl.5016
◽
2018
◽
Vol 36
(15_suppl)
◽
pp. 5016-5016
Author(s):
Karen A. Autio
◽
Emmanuel S. Antonarakis
◽
Tina M. Mayer
◽
Ulka N. Vaishampayan
◽
Daniel H. Shevrin
◽
...
Keyword(s):
Prostate Cancer
◽
Radical Prostatectomy
◽
Abiraterone Acetate
◽
Phase 2
◽
Recurrent Prostate Cancer
Download Full-text
Urethra-Sparing Stereotactic Body Radiation Therapy for Prostate Cancer: Quality Assurance of a Randomized Phase 2 Trial
International Journal of Radiation Oncology*Biology*Physics
◽
10.1016/j.ijrobp.2020.06.002
◽
2020
◽
Vol 108
(4)
◽
pp. 1047-1054
◽
Cited By ~ 1
Author(s):
Maud Jaccard
◽
Thomas Zilli
◽
Angèle Dubouloz
◽
Lluís Escude
◽
Sandra Jorcano
◽
...
Keyword(s):
Prostate Cancer
◽
Quality Assurance
◽
Radiation Therapy
◽
Stereotactic Body Radiation Therapy
◽
Phase 2
◽
Stereotactic Body Radiation
◽
Phase 2 Trial
◽
Randomized Phase 2
Download Full-text
TheraP: a randomized phase 2 trial of 177 Lu-PSMA-617 theranostic treatment vs cabazitaxel in progressive metastatic castration-resistant prostate cancer (Clinical Trial Protocol ANZUP 1603)
BJU International
◽
10.1111/bju.14876
◽
2019
◽
Vol 124
◽
pp. 5-13
◽
Cited By ~ 20
Author(s):
Michael S. Hofman
◽
Louise Emmett
◽
John Violet
◽
Alison Y. Zhang
◽
Nicola J. Lawrence
◽
...
Keyword(s):
Prostate Cancer
◽
Clinical Trial
◽
Cancer Clinical Trial
◽
Trial Protocol
◽
Phase 2
◽
Castration Resistant Prostate Cancer
◽
Clinical Trial Protocol
◽
Phase 2 Trial
◽
Castration Resistant
◽
Randomized Phase 2
Download Full-text
659 PHASE 2 TRIAL OF NEOADJUVANT LHRH PLUS ESTRAMUSTINE FOR HIGH RISK PROSTATE CANCER FOLLOWED BY RADICAL PROSTATECTOMY
The Journal of Urology
◽
10.1016/j.juro.2010.02.1046
◽
2010
◽
Vol 183
(4S)
◽
Cited By ~ 1
Author(s):
Takuya Koie
◽
Teppei Okamoto
◽
Kengo Imanishi
◽
Naoki Sugiyama
◽
Yuichiro Suzuki
◽
...
Keyword(s):
Prostate Cancer
◽
High Risk
◽
Radical Prostatectomy
◽
Phase 2
◽
High Risk Prostate Cancer
◽
Phase 2 Trial
◽
Risk Prostate Cancer
Download Full-text
Phase 2 trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer
Prostate Cancer and Prostatic Diseases
◽
10.1038/s41391-020-0211-9
◽
2020
◽
Cited By ~ 3
Author(s):
Mitchell E. Gross
◽
David B. Agus
◽
Tanya B. Dorff
◽
Jacek K. Pinski
◽
David I. Quinn
◽
...
Keyword(s):
Prostate Cancer
◽
Monoamine Oxidase
◽
Monoamine Oxidase Inhibitor
◽
Oxidase Inhibitor
◽
Phase 2
◽
Recurrent Prostate Cancer
◽
Phase 2 Trial
Download Full-text
Tasquinimod Mechanism of Action Biomarkers: Correlation with PFS and Survival in Men with Metastatic Castrate Resistant Prostate Cancer Treated in a Randomized Phase 2 Trial
Annals of Oncology
◽
10.1016/s0923-7534(20)33477-3
◽
2012
◽
Vol 23
◽
pp. ix303
◽
Cited By ~ 2
Author(s):
M. Carducci
◽
A. Armstrong
◽
M. Häggman
◽
W.M. Stadler
◽
J.R. Gingrich
◽
...
Keyword(s):
Prostate Cancer
◽
Mechanism Of Action
◽
Phase 2
◽
Phase 2 Trial
◽
Castrate Resistant Prostate Cancer
◽
Castrate Resistant
◽
Randomized Phase 2
Download Full-text
A Randomized Phase 2 Trial of 177Lu Radiolabeled Anti-PSMA Monoclonal Antibody J591 in Patients with High-Risk Castrate Biochemically Relapsed Prostate Cancer
10.21236/ada553447
◽
2011
◽
Author(s):
Scott T. Tagawa
Keyword(s):
Prostate Cancer
◽
Monoclonal Antibody
◽
High Risk
◽
Phase 2
◽
Phase 2 Trial
◽
Randomized Phase 2
Download Full-text
A Randomized Phase 2 Trial of 177Lu Radiolabeled Anti-PSMA Monoclonal Antibody J591 in Patients With High-Risk Castrate Biochemically Relapsed Prostate Cancer
10.21236/ada623383
◽
2015
◽
Author(s):
Scott T. Tagawa
Keyword(s):
Prostate Cancer
◽
Monoclonal Antibody
◽
High Risk
◽
Phase 2
◽
Phase 2 Trial
◽
Randomized Phase 2
Download Full-text
Randomized phase 2 trial of ketoconazole and ketoconazole/doxorubicin in androgen independent prostate cancer
Urologic Oncology Seminars and Original Investigations
◽
10.1016/s1078-1439(00)00123-x
◽
2001
◽
Vol 6
(3)
◽
pp. 111-115
◽
Cited By ~ 44
Author(s):
Randall Millikan
◽
Luis Baez
◽
Tarit Banerjee
◽
James Wade
◽
Kimberly Edwards
◽
...
Keyword(s):
Prostate Cancer
◽
Phase 2
◽
Phase 2 Trial
◽
Randomized Phase 2
◽
Androgen Independent
Download Full-text
665 EFFECT OF NEOADJUVANT ABIRATERONE ACETATE PLUS LEUPROLIDE ACETATE ON PSA, PATHOLOGIC RESPONSE, AND INTRAPROSTATIC/SERUM ANDROGEN LEVELS IN LOCALIZED HIGH-RISK PROSTATE CANCER: RESULTS OF A RANDOMIZED PHASE 2 STUDY
The Journal of Urology
◽
10.1016/j.juro.2013.02.220
◽
2013
◽
Vol 189
(4S)
◽
Author(s):
Jerome P. Richie
◽
Robert B. Montgomery
◽
Christopher J. Logothetis
◽
Glenn J. Bubley
◽
Bruce L. Dalkin
◽
...
Keyword(s):
Prostate Cancer
◽
High Risk
◽
Abiraterone Acetate
◽
Pathologic Response
◽
Phase 2
◽
High Risk Prostate Cancer
◽
Phase 2 Study
◽
Risk Prostate Cancer
◽
Randomized Phase 2
◽
Androgen Levels
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close